Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques: Molecular Therapy
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts | Nature Communications
Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China - Tian - 2022 - Journal of Medical Virology - Wiley Online Library
Biomedicines | Free Full-Text | Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2 - ScienceDirect
Cells | Free Full-Text | Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era - ScienceDirect
Viruses | Free Full-Text | SARS-CoV-2: Evolution and Emergence of New Viral Variants
COVID-19 vaccine - Wikipedia
Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination | Journal of Virology
Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2 - ScienceDirect
Contextualizing Wastewater-Based surveillance in the COVID-19 vaccination era - ScienceDirect
Beta RR-50
Coronavirus disease 2019 (COVID-19) - Etiology | BMJ Best Practice US
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques: Molecular Therapy
Vaccines | Free Full-Text | Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
Keeping up with the COVID's—Could siRNA‐based antivirals be a part of the answer? - Forgham - 2022 - Exploration - Wiley Online Library
Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts | Nature Communications
SARS‐CoV‐2 variants and vulnerability at the global level - Chavda - 2022 - Journal of Medical Virology - Wiley Online Library
